This medtech stock began trading less than a month ago. Goldman Sachs thinks it could double
- Posted on June 2, 2026
- By CNBC
- 0 Views
- 1 min read
This medtech stock began trading less than a month ago. Goldman Sachs thinks it could double
The investment bank initiated coverage of the neurostimulation therapy developer with a buy rating.
